Weill Cornell

The Qiagen-led Allele Frequency Community, founded in 2015, is improving the diagnosis of rare diseases by offering ethnically diverse reference sets.

Bursts of Activity

The NASA Twins Study says being in space leads to altered DNA methylation and expression, Space.com reports.

In Genome Biology this week: computational tool to uncover cancer driver mutations, microbial species linked to ankylosing spondylitis, and more.

The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.

"Precision metagenomics" and "geospatially informed medical care" are among the long-term goals of the $5 million WorldQuant Initiative for Quantitative Prediction at Weill Cornell Medicine.

The medical school is launching the program with the support of a $5 million gift from investment firm WorldQuant and its founder.

Groups from Austria, Spain, Germany, and the US demonstrated that the GeneReader can reliably detect cancer mutations in tissue and liquid biopsy samples.

With new research and commercial test launches, clincians anticipate exciting new tools but judging quality and utility has become challenging.

Researchers hope to identify exosomal biomarkers that can predict or detect cancer recurrence and metastasis at its earliest stages.

This Week in Cell

In Cell this week: essential genes in AML, indel hotspots affect certain genes in cancer, and more.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.